PrAtlas - Thar Process Partners with French Leader ExtrateX to Bring Prep to Process-Scale SFC to Europe

Trending...

Strategic agreement expands bioprocessing equipment (SFC systems) availability to the Pharma industry across Europe after Novasep exited the technology years ago.

PITTSBURGH - PrAtlas -- Thar Process, a leader in supercritical CO2 extraction and purification technology (SFE and SFC), today announced a partnership with ExtrateX, a premier French specialist in supercritical fluid systems, to represent and distribute its advanced SFC systems throughout Europe. This provides clients with comprehensive sales and technical support in pharmaceutical, biotech, and specialty chemical labs across the region.

"We are excited to re-enter Europe with our SFC systems," said Todd Palcic, CEO of Thar Process. "SFC is a platform technology that utilizes upcycled CO2 for purification of natural and synthetic molecules that is both highly efficient and sustainable at the same time. ExtrateX's deep expertise in supercritical CO2 systems and strong presence across Europe make them the ideal partner."

Thar Process's Isolator™ SFC systems are designed for high-resolution separation and purification bioprocessing applications, including pharmaceutical APIs and excipients, fermented products, peptides (GLP-1s, etc.) and natural products like omega-3s and cannabinoids. The technology offers advantages in speed, efficiency, and environmental sustainability compared to conventional separation methods.

More on PrAtlas

"We are excited to partner with Thar Process and to bring some of the most advanced SFC systems to the European market," said Gonzague Choppe, CEO of ExtrateX. "This strategic collaboration brings together the complementary strengths of two companies with extensive expertise in supercritical fluid technologies. Thar Process brings some of the most advanced SFC solutions and deep chromatography expertise, while ExtrateX contributes its extensive experience in supercritical fluid technologies, process expertise, scale-up capabilities and strong European presence."

The partnership becomes effective on the first day of 2027, with ExtrateX establishing sales and support operations to serve European customers. The company will handle equipment sales, technical installation, maintenance, and customer training.

About Thar Process
Based in Pittsburgh, Pennsylvania, Thar Process is a leading developer and operator of supercritical fluid extraction and purification systems. With deep expertise spanning laboratory R&D, contract processing, and equipment development, Thar Process serves the pharmaceutical, biotech, specialty chemical, and industrial sectors with innovative supercritical fluid chromatography (SFC) and extraction solutions designed for efficiency, sustainability, and superior results. https://www.TharProcess.com

More on PrAtlas

About ExtrateX

EXTRATEX is a France-based leader in supercritical fluid technology, delivering advanced equipment and process solutions for applications ranging from R&D and process development to pilot and industrial scale. Drawing on extensive expertise in supercritical fluid processes and equipment engineering, EXTRATEX serves leading companies across the food, nutraceutical, pharmaceutical, cosmetic and fragrance industries. With a growing installed base and a strong technical support network across Europe, EXTRATEX is a trusted technology partner for the development, scale-up and implementation of innovative supercritical processes. https://www.extraxtex-sfi.com

Contact
Todd Palcic
CEO
Thar Process
***@tharprocess.com

Source: Thar Process LLC

0 Comments

Latest on PrAtlas